Find a Doctor or Practice Location

Are you a referring physician?
within
I am searching for a
Reset Form
Arati Desai, MD

Arati Desai, MD Physician

Assistant Professor of Clinical Medicine

Dr. Desai is employed by Penn Medicine.

Patient Satisfaction Ratings

Patient Rating Breakdown

The Patient Satisfaction Rating is an average of all responses to the care provider related questions shown below from our nationally-recognized Press Ganey Patient Satisfaction Survey. Patients that are treated in outpatient or hospital environments may receive different surveys, and the volume of responses will vary by question.

Responses are measured on a scale of 1 to 5 with 5 being the best score.

The comments are submitted by patients and reflect their views and opinions. The comments are not endorsed by and do not necessarily reflect the views of Penn Medicine.

Overall Ratings

Patient Comments

Clinical Specialties

Specialty:

  • Medical Oncology

Programs & Centers:

Board Certification:

  • Hospice and Palliative Medicine, 2012
  • Medical Oncology, 2008

Clinical Expertise:

  • Brain Tumors

Practice Locations and Appointments

  • Abramson Cancer Center

    Perelman Center for Advanced Medicine West Pavilion, 2nd Floor 3400 Civic Center Boulevard Philadelphia, PA 19104 800-789-7366 (PENN)

    A facility of the Hospital of the University of Pennsylvania

Insurance Accepted

  • Aetna US Healthcare
  • Cigna
  • Cigna HealthSpring
  • CVS Health
  • Devon Health Services (Americare)
  • Gateway Health Plan
  • Geisinger Health Plan
  • HealthAmerica / HealthAssurance, a Coventry Plan
  • HealthPartners
  • HealthPartners Medicare
  • HealthSmart
  • Highmark Blue Shield
  • Horizon Blue Cross Blue Shield of New Jersey
  • Humana / Choicecare
  • Independence Blue Cross (Keystone East)
  • Intergroup
  • Keystone First
  • Keystone First Medicare
  • Multiplan
  • NJ Medicaid
  • NJ Qualcare
  • Oxford Health Plan
  • PA Medicaid
  • PA Medicare
  • Preferred Health Care/LGH
  • Rail Road Medicare / Palmetto GBA
  • Remedy Partners at Penn Medicine
  • Tricare
  • United Healthcare
  • UnitedHealthcare Community Plan
  • US Family Health Plan

Education and Training

Medical School: University of Kentucky
Residency: University of Texas Southwestern Medical Center
Fellowship: UCSF Medical Center and Hospital
Fellowship: Johns Hopkins Hospital

Memberships

Adult Brain Tumor Consortium, National American Society of Clinical Oncology, International Society for Neuro-Oncology, International

Hospital Affiliation

Dr. Desai is employed by Penn Medicine.

Hospital Privileges:

  • Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
  • Penn Presbyterian Medical Center: Has privileges to treat patients in the hospital.

Research

Selected Publications:

O'Rourke Donald M, *Nasrallah MacLean P, *Desai Arati, *Melenhorst Jan J, Mansfield Keith, Morrissette Jennifer J D, Martinez-Lage Maria, Brem Steven, Maloney Eileen, Shen Angela, Isaacs Randi, Mohan Suyash, Plesa Gabriela, Lacey Simon F, Navenot Jean-Marc, Zheng Zhaohui, Levine Bruce L, Okada Hideho, June Carl H, Brogdon Jennifer L, Maus Marcela V: A single dose of peripherally infused EGFRvIII-directed CAR T cells mediates antigen loss and induces adaptive resistance in patients with recurrent glioblastoma. Science Translational Medicine 9 (399): 2017.

Nasrallah MacLean P, Nasrallah Ilya M, Prelack Marisa S, Johnson Margaret O, Lewis Travis B, Rubenstein Michael, Minturn Jane E, Desai Arati, Marcotte Paul, Santi Mariarita, Martinez-Lage Maria: 19-Year-Old Male with Headaches and a Possible Seizure. Brain pathology (Zurich, Switzerland) 27 (4): 557-558,2017.

Holdhoff Matthias, Ye Xiaobu, Supko Jeffrey G, Nabors Louis B, Desai Arati S, Walbert Tobias, Lesser Glenn J, Read William L, Lieberman Frank S, Lodge Martin A, Leal Jeffrey, Fisher Joy D, Desideri Serena, Grossman Stuart A, Wahl Richard L, Schiff David: Timed sequential therapy of the selective T-type calcium channel blocker mibefradil and temozolomide in patients with recurrent high-grade gliomas. Neuro-oncology 19 (6): 845-852,2017.

Lodge Martin A, Holdhoff Matthias, Leal Jeffrey P, Bag Asim K, Nabors L Burt, Mintz Akiva, Lesser Glenn J, Mankoff David A, Desai Arati S, Mountz James M, Lieberman Frank S, Fisher Joy D, Desideri Serena, Ye Xiaobu, Grossman Stuart A, Schiff David, Wahl Richard L: Repeatability of (18)F-FLT PET in a Multicenter Study of Patients with High-Grade Glioma. Journal of nuclear medicine : official publication, Society of Nuclear Medicine 58 (3): 393-398,2017.

Evans Sydney M, Putt Mary, Yang Xiang-Yang, Lustig Robert A, Martinez-Lage Maria, Williams Dewight, Desai Arati, Wolf Ronald, Brem Steven, Koch Cameron J: Initial evidence that blood-borne microvesicles are biomarkers for recurrence and survival in newly diagnosed glioblastoma patients. Journal of neuro-oncology : 2016.

S. Wang, M. Martinez-Lage, Y. Sakai, S. Chawla, S.G. Kim, M. Alonso-Basanta, R.A. Lustig, S. Brem, S. Mohan, R.L. Wolf, A. Desai,and H. Poptani : Differentiating Tumor Progression from Pseudoprogression in Patients with Glioblastomas Using Diffusion Tensor Imaging and Dynamic Susceptibility Contrast MRI American Journal of Neuroradiology 37 : 28-36,2016.

Donald M. O'Rourke, MacLean Nasrallah, Jennifer J. Morrissette, Jan J. Melenhorst, Simon F. Lacey, Keith Mansfield, Maria Martinez-Lage, Arati Suvas Desai, Steven Brem, Eileen Maloney, Suyash Mohan, Sumei Wang, Gaurav Verma, Jean-Marc Navenot, Angela Shen, Zhaohui Zheng, Bruce Levine, Hideho Okada, Carl H. June, Marcela Valderrama Maus; University of Pennsylvania, Philadelphia, PA; Perelman School of Medicine at the University of Pennsylvania: Pilot study of T cells redirected to EGFRvIII with a chimeric antigen receptor in patients with EGFRvIII+ glioblastoma. ASCO Annual Meeting, Journal of Clinical Oncology 34, 2016 (suppl; abstr 2061) 34 : 2016.

Steven Brem, Eric T. Wong, Arati Desai, Yi Fan, and Edward Pan: Angiogenesis and Brain Tumors: Scientific Principles, Current Therapy, and Future Directions Youmans and Winn Neurological Surgery 7th Edition. Chapter 116. : 2016.

Donald O’Rourke, Arati Desai, Jennifer Morrissette, Maria Martinez-Lage, MacLean Nasrallah, Steven Brem, Eileen Maloney, Angela Shen, SuyashMohan, SumeiWang, GauravVerma, Simon Lacey, Jan Melenhorst, Jean-Marc Navenot, Zhaohui Zheng, Bruce Levine, HidehoOkada, Carl June, and Marcela Maus: PILOT STUDY OF T CELLS REDIRECTED TO EGFRvIII WITH A CHIMERIC ANTIGEN RECEPTOR IN PATIENTS WITH EGFRvIII1 GLIOBLASTOMA Neuro-Oncology 17 (IMCT-15): 2015.

Matthias Holdhoff, Martin A. Lodge, Asim K. Bag, L. Burt Nabors, Akiva Mintz, Glenn J. Lesser, David A. Mankoff, Arati S. Desai, Frank S. Lieberman, Jeffrey Leal, Joy D. Fisher, Serena Desideri, Xiaobu Ye, Stuart A. Grossman, David Schiff, and Richard L. Wahl: RESULTS OF EXPLORATORY 18F-FLT PET IMAGING IN TEN RECURRENT HIGH-GRADE GLIOMA PATIENTS TREATED WITH THE SELECTIVE T-TYPE CALCIUM CHANNEL BLOCKER MIBEFRADIL FOLLOWED BY TEMOZOLOMIDE (ABTC TRIAL 1101) Neuro-Oncology 17 (NIMG-35): 2015.

Academic Contact Info

Division of Hematology Oncology
Perelman Center for Advanced Medicine
10th Floor, South Pavilion
Office #10-307
3400 Civic Center Boulevard

Philadelphia, PA 19104
Phone: (215) 349-8140
Patient appointments: 800-789-7366 (PENN)

Related Links